Old Web
English
Sign In
Acemap
>
authorDetail
>
Anas Younes
Anas Younes
University of Texas Health Science Center at Houston
Medicine
Phases of clinical research
Immunology
Lymphoma
Oncology
4
Papers
250
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Biomarker analysis of pivotal phase II study of oral panobinostat (PAN) in relapsed/refractory Hodgkin lymphoma (HL) patients following autologous stem cell transplant (ASCT).
2011
Journal of Clinical Oncology
Simon J. Harrison
Andy Hsu
Paul Neeson
Anas Younes
Anna Sureda
Andreas Engert
Marilyn Li
Paula Savage
Roberto Bugarini
C. Le Corre
Denise Williams
J. D. Gallagher
Angela Shen
David Ritchie
Show All
Source
Cite
Save
Citations (10)
Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)
2010
Journal of Clinical Oncology
Anna Sureda
Andreas Engert
P. J Browett
John Radford
Gregor Verhoef
Rod Ramchandren
N Myke
Angela Shen
C. Le Corre
Anas Younes
Show All
Source
Cite
Save
Citations (14)
Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592)
2010
Blood
Arnold S. Freedman
John Kuruvilla
Sarit Assouline
Andreas Engert
Dae Seog Heo
Philippe Solal-Celigny
Paolo Corradini
Gregor Verhoef
Michelle A. Fanale
Jennifer Bendiske
Brett Ewald
Jyotirmoy Dey
Johan Baeck
Anas Younes
Show All
Source
Cite
Save
Citations (14)
A Phase II study of SGN‐30 (anti‐CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
2009
British Journal of Haematology
Andres Forero-Torres
John P. Leonard
Anas Younes
Joseph D. Rosenblatt
Pauline Brice
Nancy L. Bartlett
André Bosly
Lauren Pinter-Brown
Dana A. Kennedy
Eric L. Sievers
Ajay K. Gopal
Show All
Source
Cite
Save
Citations (212)
1